RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,556,380 | -33.0% | 185,063 | 0.0% | 0.56% | -32.2% |
| Q2 2023 | $2,324,391 | -23.7% | 185,063 | 0.0% | 0.82% | -29.6% |
| Q1 2023 | $3,047,988 | +10.2% | 185,063 | 0.0% | 1.17% | +2.3% |
| Q4 2022 | $2,764,841 | -33.2% | 185,063 | 0.0% | 1.14% | -34.5% |
| Q3 2022 | $4,140,000 | +33.5% | 185,063 | 0.0% | 1.75% | +30.7% |
| Q2 2022 | $3,100,000 | -44.0% | 185,063 | 0.0% | 1.34% | -31.3% |
| Q1 2022 | $5,539,000 | -2.5% | 185,063 | 0.0% | 1.94% | +4.6% |
| Q4 2021 | $5,683,000 | -2.6% | 185,063 | 0.0% | 1.86% | -7.3% |
| Q3 2021 | $5,835,000 | -13.8% | 185,063 | 0.0% | 2.00% | -10.5% |
| Q2 2021 | $6,771,000 | +5.8% | 185,063 | 0.0% | 2.24% | -4.8% |
| Q1 2021 | $6,398,000 | -7.1% | 185,063 | +11.7% | 2.35% | -13.3% |
| Q4 2020 | $6,884,000 | -2.4% | 165,639 | 0.0% | 2.71% | -18.6% |
| Q3 2020 | $7,055,000 | – | 165,639 | – | 3.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |